Level Bio ABNGM: LEVBIO

LEVBIO: Flat sales but improved results and cash flow signal operational progress and future growth

· Issued by Level Bio AB

Net sales were flat year-over-year at 6,421 KSEK, but operating loss and cash flow improved significantly. Cost reductions, new distribution agreements, and a directed share issue support a positive outlook for growth and financial stability.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Level Bio AB on 6ix

Earlier from Level Bio

Later from Level Bio

All Level Bio news releases